Rectification Of Intimation Filed Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Dated 16.03.2018. :EIR Received From USFDA For Our Formulation Unit At Jadcherla, Telangana

• Security Code: 530549
• Company: SHILPAMED

This is to inform you that the US FDA has issued an Establishment Inspection Report (EIR) for our Company's formulations manufacturing facility (SEZ unit) located at Jadcherla, Telangana, India which was inspected between 11th November and 30th November 2017. FDA has determined that the inspection classification of this facility is VAI and accordingly EIR issued.

We wish to confirm that earlier status of our formulation unit is maintained.

This is for your information and doing the needful.